| Q38992554 | Comparison between the traditional non-guided and a novel ultrasound-guided technique for office fitting of intrauterine contraceptive devices. |
| Q50028271 | Comparison of the Pharmacokinetics and Pharmacodynamics of Single-Dose Tenofovir Vaginal Film and Gel Formulation (FAME 05). |
| Q88971038 | Contraceptive Practices, Preferences, and Barriers Among Abortion Clients in North Carolina |
| Q58747976 | Contraceptive, condom and dual method use at last coitus among perinatally and horizontally HIV-infected young women in Atlanta, Georgia |
| Q90058235 | Cost Minimization Analysis of Same-Day Long-Acting Reversible Contraception for Adolescents |
| Q42616236 | Diagnosis and Management of Polycystic Ovary Syndrome in Adolescent Girls |
| Q95284240 | Effect of a mobile phone-assisted postpartum family planning service on the use of long-acting reversible contraception: a randomised controlled trial |
| Q47664181 | High birth rates despite easy access to contraception and abortion: a cross-sectional study |
| Q99608093 | Increasing the uptake of long-acting reversible contraception in general practice: the Australian Contraceptive ChOice pRoject (ACCORd) cluster randomised controlled trial longitudinal follow-up protocol |
| Q92186665 | Interventions for the prevention of pain associated with the placement of intrauterine contraceptives: An updated review |
| Q38569796 | Investigational hormone receptor agonists as ongoing female contraception: a focus on selective progesterone receptor modulators in early clinical development |
| Q92070408 | Long-acting reversible contraception: A route to reproductive justice or injustice |
| Q49467295 | New developments in intrauterine device use: focus on the US. |
| Q40632023 | Peer counselling for the promotion of long-acting, reversible contraception among teens: a randomised, controlled trial |
| Q90682256 | Perceptions matter: Narratives of contraceptive implant robbery in Cape Town, South Africa |
| Q38831516 | Pipeline for contraceptive development |
| Q35799214 | Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding |
| Q37737961 | Reversibility of Vasalgel™ male contraceptive in a rabbit model |
| Q49499945 | Safety of hormonal contraception for obese women |
| Q58617257 | State-Identified Implementation Strategies to Increase Uptake of Immediate Postpartum Long-Acting Reversible Contraception Policies |
| Q92161388 | Strength through Structure: Defending a Structured Approach to Contraceptive Mandates in Clinical Research |
| Q37030520 | The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding |
| Q55461506 | Women's perceptions of contraceptive efficacy and safety. |
| Q92485368 | Young Women's Perspectives About the Contraceptive Counseling Received During Their Emergency Contraception Visit |